Search research articles
Contact Us
Filters
Showing results (51-60 of 85) with videos related to
Page
of 9
Sort By:
Cancers
|
September 2, 2020
Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching
Maike Trommer, Jaika Kinsky, Anne Adams, et al.
Molecular Imaging and Biology
|
June 30, 2022
Head-to-Head Comparison of [<sup>68</sup> Ga]Ga-FAPI-46-PET/CT and [<sup>18</sup>F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
Simone Wegen, Lutz van Heek, Philipp Linde, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group
Jan Kriz, Gabriele Reinartz, Markus Dietlein, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2024
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group
Johannes Rosenbrock, Helen Kaul, Michael Oertel, et al.
Clinical Nuclear Medicine
|
January 6, 2023
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer
Simone Wegen, Katrin Sabine Roth, Jasmin Weindler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group
Stephanie Sasse, Helen Goergen, Annette Plütschow, et al.
Advances in Radiation Oncology
|
March 10, 2023
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era
Michael Oertel, Dominik Hering, Nina Nacke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2020
Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial
Conrad-Amadeus Voltin, Jasmin Mettler, Lutz van Heek, et al.
Blood
|
May 31, 2023
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies
Dennis A Eichenauer, Ina Bühnen, Christian Baues, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
Jan-Michael Werner, Johannes Weller, Garry Ceccon, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 85) with videos related to
Sort By:
Page
of 9
Cancers
|
September 2, 2020
Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching
Maike Trommer, Jaika Kinsky, Anne Adams, et al.
Molecular Imaging and Biology
|
June 30, 2022
Head-to-Head Comparison of [<sup>68</sup> Ga]Ga-FAPI-46-PET/CT and [<sup>18</sup>F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
Simone Wegen, Lutz van Heek, Philipp Linde, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group
Jan Kriz, Gabriele Reinartz, Markus Dietlein, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2024
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group
Johannes Rosenbrock, Helen Kaul, Michael Oertel, et al.
Clinical Nuclear Medicine
|
January 6, 2023
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer
Simone Wegen, Katrin Sabine Roth, Jasmin Weindler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group
Stephanie Sasse, Helen Goergen, Annette Plütschow, et al.
Advances in Radiation Oncology
|
March 10, 2023
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era
Michael Oertel, Dominik Hering, Nina Nacke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2020
Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial
Conrad-Amadeus Voltin, Jasmin Mettler, Lutz van Heek, et al.
Blood
|
May 31, 2023
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies
Dennis A Eichenauer, Ina Bühnen, Christian Baues, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
Jan-Michael Werner, Johannes Weller, Garry Ceccon, et al.
Page
of 9